Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

scientific article published on 27 August 2015

Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3174/AJNR.A4436
P698PubMed publication ID26316568

P50authorVincent DeramecourtQ51346936
Olivier OutteryckQ64095683
P2093author name stringP Vermersch
A Lacour
J Hodel
X Leclerc
J-P Pruvo
S Verclytte
P2860cites workMagnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.Q30583907
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease SectionQ30613846
The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathyQ30689194
Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imagingQ30820686
Outcome and survival of asymptomatic PML in natalizumab-treated MS patientsQ34562841
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 casesQ37714089
MRI pattern in asymptomatic natalizumab-associated PML.Q41745436
Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?Q43897444
JC virus infection of the brainQ45377474
P433issue12
P921main subjectprogressive multifocal leukoencephalopathyQ704930
P304page(s)2296-2302
P577publication date2015-08-27
P1433published inAmerican Journal of NeuroradiologyQ15762571
P1476titleBrain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
P478volume36

Reverse relations

cites work (P2860)
Q33810020Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study
Q36352813Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression.
Q40039520Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
Q48094258Low Signals on T2* and SWI Sequences in Patients with MS with Progressive Multifocal Leukoencephalopathy.
Q40168148Low-signal Intensity Rims along the Cerebral Cortex and U-fibers on Susceptibility-weighted Imaging in Progressive Multifocal Leukoencephalopathy.
Q47433677Pathologic Correlation of Paramagnetic White Matter Lesions in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
Q30245002Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.
Q52718488Progressive multifocal leukoencephalopathy after fingolimod treatment.
Q58007550REPLY:
Q38659676Susceptibility-Based Neuroimaging: Standard Methods, Clinical Applications, and Future Directions
Q90288758Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration

Search more.